ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2369

Aspects of Innate Immunity in Behçet´s Disease: A Model of Autoinflammatory Disease?

Sandro F. Perazzio1, Paulo Vitor Soeiro Pereira2, Alexandre Wagner S. de Souza3, Antonio Condino-Neto2 and Luis Eduardo C. Andrade4, 1Rheumatology, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 2Immunology, ICB IV - Universidade de São Paulo, São Paulo, Brazil, 3Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 4Rheumatology Division, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome, immune response and neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Behçet’s disease (BD) is a systemic vasculitis of unknown etiopathogenesis. Increased neutrophil activation has been previously shown in BD patients and it is unclear whether neutrophil activation occurs constitutively or if it is secondary to a yet unknown stimulus or some serum or tissue soluble factor. The hypersensitivity to Streptococcus sanguinis antigens suggests that infectious agents may play a role in BD pathogenesis. Recently, it has been postulated that BD may be a form of auto-inflammatory disease. The present study investigated several aspects of cellular activation in neutrophils and peripheral blood mononuclear cells (PBMC) of patients with active and inactive BD.

Methods: four study groups were analyzed: active BD (aBD; n=17), inactive BD (iBD; n=26); septic patients (SP; n=10); healthy controls (HC; n=10). BD activity was established as Behçet’s Disease Current Activity Form simplified (BDCAFs) score³2. Flow cytometry analysis evaluated phagocytosis (zymosan particles, Stretococcus pneumoniae and Candida albicans) and the oxidative metabolism before and after stimulation with phorbol myristate acetate (PMA). The shedding of CD62L was determined after stimulation of TLR-2, -3, -4, -5, -7. Microbicidal activity against Streptococcus and Candida was determined by means of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction and absorbance read by ELISA. The supernatant of PBMC cultures under TLR or microbial stimuli were used for determination of TNFa, IFNg, IL-12p70, IL-23, IL-6 and IL-10 by ELISA. The supernatant of neutrophil cultures under PMA, LPS or microbial stimuli were used for determination of IL-1β and IL-8.

Results: There was no difference in medication use between aBD and iBD. Phagocytosis, microbial killing activity and oxidative burst assays in PMN and monocytes showed no difference among the four groups. The activated monocyte index of shedding assay showed higher activation by TLR3 in iBD (31±28%, p=0.022) and aBD (27±20%, p=0.029) than in SP (3.4±25%). In contrast, the activation by TLR7 was lower in iBD (27±23%, p=0.022) and aBD (32±27%, p=0.029) than in SP (74±39%). BD monocytes did not differ from HC monocytes regarding activation via TLR stimuli. Neutrophils from aBD produced less IL-1β after stimulus with S. pneumoniae (68±61 pg/mL) than HC (273±174 pg/mL, p=0.05) and showed a trend for lower values comparing to iBD (175±93 pg/mL, p=0.076). There was no difference in the production rate of other cytokines.

Conclusion:

These results showed that phagocytes in BD are not constitutively activated. This negative evidence suggests that the marked involvement of neutrophils in BD pathophysiology may be caused by some kind of stimuli produced by other cells at or close to the target tissues. Thence, further studies should address proteomic analyses of the serum and samples from target tissues in BD in an attempt to identify possible metabolic pathways involved in neutrophil activation in BD.


Disclosure:

S. F. Perazzio,
None;

P. V. S. Pereira,
None;

A. W. S. de Souza,
None;

A. Condino-Neto,
None;

L. E. C. Andrade,

Fleury Medicine and Health Laboratories,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/aspects-of-innate-immunity-in-behcets-disease-a-model-of-autoinflammatory-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology